In a public statement, the Health and Disability Commissioner (HDC) has found that three optometrists employed by Specsavers Silverdale on Auckland’s North Shore over five years failed to provide an appropriate standard of care for a female glaucoma patient.
A novel robotic surgical system could dramatically improve outcomes for patients with glaucoma, given its remarkable level of precision, claims a team of research developers.
New research led by scientists at the University of Washington, US, indicates that a common mosquito species detects exhaled CO2 then flies toward specific colours such as red, orange, black and cyan, while ignoring green, purple, blue and white.
Apellis Pharmaceuticals’ 18-month phase-3 study results for pegcetacoplan (Empaveli) continued to show promise that a treatment for geographic atrophy (GA) secondary to age-related macular degeneration (AMD) was now a real possibility.
The Royal Australian and New Zealand College of Ophthalmologists (RANZCO) has joined nine other medical colleges to advocate for urgent transition to net-zero emissions across all economic sectors to address the causes of climate change and to support those in affected communities.
Swiss startup Mikajaki has teamed up with engineering group Segula Technologies to bring its prototype EyeLib ophthalmic diagnostic station to the European market.
A Canadian study has shown cannabinol (CBN) promotes neuroprotection, abrogates changes in extracellular matrix (ECM) protein and normalises intraocular pressures (IOPs), indicating the compound’s therapeutic potential in the treatment of glaucoma, said study authors.
Researchers at Ireland’s Trinity College Dublin reported they have identified a single gene, SARM1, that is a key driver of vision impairment and blindness.
American actress and singer-songwriter Mandy Moore, the voice of Disney’s Princess Rapunzel, is a dry-eye sufferer and the new brand ambassador for Lumenis’ OptiLight.
To better serve New Zealand’s high proportion of keratoconus sufferers, a team of Auckland University researchers has initiated a study to evaluate the complexities of managing keratoconus patients and gain more understanding of diagnostic and referral patterns.
Dutch researchers are developing an RNA therapy to target the gene responsible for vision loss in Stargardt disease.
A Flinders University study found high levels of anxiety, fear and initial shock among caregivers of young people living with childhood glaucoma, some of whom have been diagnosed with genetic glaucoma